Novo Nordisk announced clinical results from the first of five phase 3 studies with liraglutide -- the once-daily human GLP-1 analog.
Ads by Google
Mexican Diabetes Federation has given Biotech's "Sucanon" diabetes drug its support in an overview of diabetic drugs published in the May-June 2007 issue of Diabetes Hoy.
One out of every eight federal health care dollars is spent treating people with diabetes.
Death rates for men with diabetes fell steeply, but rates for women with diabetes did not change.
ARKRAY USA has started to sell its Assure 4 Blood Glucose Monitoring System to the Long Term Care (LTC) market.
NBA Hall-of-Famer Dominique Wilkins and former U.S. House Speaker Newt Gingrich will hold a press conference on June 11, to announce a joint effort to fight diabetes in Georgia and beyond.
U.S. Food and Drug Administration approved a device that measures glucose levels continuously for up to seven days in people with diabetes.
AAPPO is launching a new initiative to help PPO providers offer the highest quality care to those patients diagnosed with diabetes as well as encourage wellness efforts to prevent the disease.
The legislation "Diabetes Management in Schools Act" is signed, that will help ensure that Oklahoma public schools are responsive to the medical and educational needs of students with diabetes.
While diabetes contributes to nearly a quarter million deaths in the United States annually, patients with chronic ailments don't always take their medication as prescribed.
Governor Edward G. Rendell signed two executive orders to improve how Pennsylvanians with chronic diabetes receive health care in the future.
A drug commonly used to treat patients with type 2 diabetes mellitus, raises patients' risk of heart attack and cardiovascular death.
Spending money to improve diabetes care at federally qualified community health centers is a sound investment.
In the most comprehensive look at genetic risk factors for type 2 diabetes to date, a U.S. Finnish team has identified at least four new genetic variants associated with increased risk of diabetes and confirmed existence of another six.
Treating wounds with honey has tremendous potential for the approximately 200 million people in the world with diabetes, 15 percent of whom will develop an ulcer.
Seattle and King County highlights trends and health inequities in diabetes, a disease that now affects more than 84,000 King County adults.
A new study examining the overall and gender-related effects of laparoscopic gastric banding surgery (LGBS) on insulin resistance, body composition, and metabolic risk markers six months post-surgery has found significant improvements in insulin resistance.
Researchers believe impaired intestinal metabolic function, effected by high insulin levels, plays a critical role in the development of cardiovascular disease.
The Chrysler Group announced that it will expand its innovative diabetes care program, "Driving DCX," to its Sterling Heights Assembly plant.
Baxter Healthcare Corporation announced results of a Phase I study that evaluated pulmonary insulin produced with Baxter's PROMAXX microsphere technology and administered using a small, standard dry powder inhaler.
In recognition of Foot Health Awareness Month, LifeMasters encourages diabetics to prevent foot complications by following a few simple steps to maintain healthy feet.
deCODE genetics announced the launch of deCODE T2, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Medicare beneficiaries will be able to purchase diabetes testingproducts from their local pharmacy.
In yet another advance in adult stem cell therapy, a study released in which 14 of 15 Juvenile Diabetes patients demonstrated significant improvement as a result of an adult stem cell treatment.